Meir Bialer, PhD, MBA, is the David H. Eisenberg Emeritus (active) Professor of Pharmacy at the School of Pharmacy of the Hebrew University of Jerusalem. Since 1980 he has been on the faculty of the School of Pharmacy of the Hebrew University of Jerusalem. Professor Bialer has been awarded the Fellow (1992) of the American Association of Pharmaceutical Scientists (AAPS), Kaye Innovation Award of the Hebrew University of Jerusalem (2000, 2007 & 2008), an Ambassador for Epilepsy Award (2001). He is the co-founder and member of the Organizing Committees of the sixteen (1992-2022) EILAT Conferences on New Antiepileptic Drugs, the nine Eilat International Educational Courses on the Pharmacological Treatment of Epilepsy (2005-2022) He has served as a member of the editorial board of: CNS Drugs, Epilepsia (2000-2010), Epilepsy& Behaviour, Epilepsy Research, and Therapeutic Drug Monitoring. Dr. Bialer’s research interests include: a) Pharmacokinetics of new antiepileptic drugs (AEDs) and pharmacokinetic-based design of new antiepileptics and CNS drugs. In this regard he has been utilizing SPPR studies to design and develop new CNS drugs with better potency, lack of teratogenicity and a wide safety margin; b) Pharmacokinetic analysis of new drugs, sustained release dosage forms and novel drug delivery systems (DDS); c) Stereospecific pharmacokinetic /pharmacodynamic analysis of chiral drugs. In these areas, he has 269 peer reviewed publications and is an author of 16 book chapters.